Eric Lalanne
Director/Board Member at Oryzon Genomics Diagnóstico SL
Profile
Eric Lalanne is currently a Director at Oryzon Genomics Diagnóstico SL.
He previously worked as a Director-In Vitro Diagnostics at Oryzon Genomics SA. Lalanne holds a doctorate degree from Université Paris 1 Panthéon-Sorbonne and undergraduate and graduate degrees from Université Toulouse III - Paul Sabatier.
Eric Lalanne active positions
Companies | Position | Start |
---|---|---|
Oryzon Genomics Diagnóstico SL
Oryzon Genomics Diagnóstico SL Medical SpecialtiesHealth Technology Oryzon Genomics Diagnóstico SL develops oncology diagnostic solutions. It operates as a IVD company that engages in developing and commercializing molecular diagnostics for oncology. The firm's product GynEC-DX, a molecular test for endometrial cancer detection. The company was founded in 2013 and is headquartered in Barcelona, Spain. | Director/Board Member | - |
Former positions of Eric Lalanne
Companies | Position | End |
---|---|---|
ORYZON GENOMICS S.A. | Corporate Officer/Principal | - |
Training of Eric Lalanne
Université Paris 1 Panthéon-Sorbonne | Doctorate Degree |
Université Toulouse III - Paul Sabatier | Graduate Degree |
Experiences
Positions held
Linked companies
Listed companies | 1 |
---|---|
ORYZON GENOMICS S.A. | Health Technology |
Private companies | 1 |
---|---|
Oryzon Genomics Diagnóstico SL
Oryzon Genomics Diagnóstico SL Medical SpecialtiesHealth Technology Oryzon Genomics Diagnóstico SL develops oncology diagnostic solutions. It operates as a IVD company that engages in developing and commercializing molecular diagnostics for oncology. The firm's product GynEC-DX, a molecular test for endometrial cancer detection. The company was founded in 2013 and is headquartered in Barcelona, Spain. | Health Technology |
- Stock Market
- Insiders
- Eric Lalanne